NCT00407927View on ClinicalTrials.gov

A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL
Enrollment

571

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

Epinastine Nasal Spray

Trial Locations (7)

76712

Allergy Asthma Research Institute, Waco

78028

Kerrville Research Associates, Kerrville

78130

Central Texas Health Research, New Braunfels

78229

Biogenics Research Institute, San Antonio

Sylvana Research Associates, San Antonio

78731

Allergy & Asthma Associates, Austin

78759

Lovelace Scientific Resources, Inc., Austin

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00407927 - A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis | Biotech Hunter | Biotech Hunter